Opportunity radar
4,186,134 patents indexed · 165,974,948 citations · issued 2005-01-04 → 2026-05-05
Showing50 of 77,862
Pharma (A61K)Therapy methods (A61P)Med devices (A61M)Agriculture (A01)Hand tools (B25)Consumer (A47)Energy (H01M)AI / ML (G06N)
| Patent # | Title | Assets | Issued | Expires | Fwd cites | Score |
|---|---|---|---|---|---|---|
| 12600762 | Masked cytokines and methods of use thereof | 🖼🧊📄§ | 2026-04-14 | 2041-01-11 | 0 | 31 |
| 12600763 | Compositions and methods for the delivery of therapeutic biologics for treatment of disease | 🖼🧊📄§ | 2026-04-14 | 2042-08-08 | 0 | 31 |
| 12600752 | Methods and compositions for recombinant dengue viruses or vaccine and diagnostic development | 🖼🧊📄§ | 2026-04-14 | 2040-11-20 | 0 | 31 |
| 12600749 | Compstatin analogues and their medical uses | 🖼🧊📄§ | 2026-04-14 | 2044-03-11 | 0 | 31 |
| 12600758 | Interleukin-2 muteins for the expansion of T-regulatory cells | 🖼🧊📄§ | 2026-04-14 | 2040-08-13 | 0 | 31 |
| 12600727 | Treatment of infections of toxoplasma gondii and closely related parasites | 🖼🧊📄§ | 2026-04-14 | 2039-09-18 | 0 | 31 |
| 12600738 | Quinolinone derivative compound selectively binding to cysteine, peptide conjugate thereof, and antibody-drug conjugate comprising same | 🖼🧊📄§ | 2026-04-14 | 2041-08-25 | 0 | 31 |
| 12599623 | Skin compositions and methods of use thereof | 🖼🧊📄§ | 2026-04-14 | 2037-06-29 | 0 | 31 |
| 12599631 | Agent for treating or preventing vascular dementia | 🖼🧊📄§ | 2026-04-14 | 2040-08-07 | 0 | 31 |
| 12599633 | Mesenchymal stem cells for use in the treatment of skin defects | 🖼🧊📄§ | 2026-04-14 | 2042-05-20 | 0 | 31 |
| 12599636 | Treatment of Krabbe disease with umbilical cord blood transplantion (UCBT) and increased galactocerebrosidase (GALC) expression | 🖼🧊📄§ | 2026-04-14 | 2038-01-19 | 0 | 31 |
| 12599637 | Genetically modified Lactobacillus and uses thereof | 🖼🧊📄§ | 2026-04-14 | 2040-02-04 | 0 | 31 |
| 12599641 | Probiotic composition for improving soy protein proteolysis and amino acid production activity | 🖼🧊📄§ | 2026-04-14 | 2044-05-28 | 0 | 31 |
| 12599642 | Compositions derived from Salvia hispanica seeds | 🖼🧊📄§ | 2026-04-14 | 2041-03-04 | 0 | 31 |
| 12599643 | Use of green coffee based compositions for improving insulin profile | 🖼🧊📄§ | 2026-04-14 | 2040-03-27 | 0 | 31 |
| 12599647 | Peptide amide composition and preparation method therefor | 🖼🧊📄§ | 2026-04-14 | 2040-08-24 | 0 | 31 |
| 12599646 | Peptide-containing composition for use for treating neoplastic lesions | 🖼🧊📄§ | 2026-04-14 | 2040-03-10 | 0 | 31 |
| 12599644 | Treatment of coronavirus infection with Flt3 receptor interacting lectin (FRIL) | 🖼🧊📄§ | 2026-04-14 | 2041-05-06 | 0 | 31 |
| 12599652 | Serum albumin-binding fibronectin type III domains | 🖼🧊📄§ | 2026-04-14 | 2043-10-27 | 0 | 31 |
| 12599650 | Inhibition of SIRP-gamma for cancer treatment | 🖼🧊📄§ | 2026-04-14 | 2040-06-23 | 0 | 31 |
| 12599653 | Thrombolytic agents for intravascular clots | 🖼🧊📄§ | 2026-04-14 | 2040-10-19 | 0 | 31 |
| 12599657 | Enhancement of vaccine efficacy via biomass and/or related material in animal drink and feed | 🖼🧊📄§ | 2026-04-14 | 2041-07-02 | 0 | 31 |
| 12599656 | Methods for treating HPV-associated diseases | 🖼🧊📄§ | 2026-04-14 | 2039-03-11 | 0 | 31 |
| 12599660 | Therapeutic RNA for HPV-positive cancer | 🖼🧊📄§ | 2026-04-14 | 2041-07-06 | 0 | 31 |
| 12599665 | Gene fusions for control of genetically modified cells | 🖼🧊📄§ | 2026-04-14 | 2041-08-12 | 0 | 31 |
| 12599668 | Antibodies | 🖼🧊📄§ | 2026-04-14 | 2040-02-20 | 0 | 31 |
| 12599663 | Multivalent peptide conjugates for sustained intra-articular treatment of joint inflammation | 🖼🧊📄§ | 2026-04-14 | 2039-03-08 | 0 | 31 |
| 12599671 | Compounds, compositions, and methods for protein degradation | 🖼🧊📄§ | 2026-04-14 | 2041-02-11 | 0 | 31 |
| 12599669 | Use of low molecular weight polyvinylpyrrolidone (PVP) to reduce viscosity of high concentration protein formulations | 🖼🧊📄§ | 2026-04-14 | 2040-04-22 | 0 | 31 |
| 12599670 | Composition comprising three-dimensional astrocyte bundles of bi-polar and aligned astrocyte processes and a method of making thereof | 🖼🧊📄§ | 2026-04-14 | 2035-12-11 | 0 | 31 |
| 12599678 | Methods and compositions for genomic integration | 🖼🧊📄§ | 2026-04-14 | 2043-05-05 | 0 | 31 |
| 12599680 | Treatments for ocular neovascularization | 🖼🧊📄§ | 2026-04-14 | 2045-08-14 | 0 | 31 |
| 12599676 | Cytotoxic imidazo[1,2-A]pyridine compounds and their use in therapy | 🖼🧊📄§ | 2026-04-14 | 2045-03-06 | 0 | 31 |
| 12599679 | Circular RNA compositions | 🖼🧊📄§ | 2026-04-14 | 2045-05-07 | 0 | 31 |
| 12599677 | Targeted PH sensitive liposomes | 🖼🧊📄§ | 2026-04-14 | 2041-10-04 | 0 | 31 |
| 12599682 | Near-infrared dyes and conjugates for targeting tumors | 🖼🧊📄§ | 2026-04-14 | 2044-10-08 | 0 | 31 |
| 12599683 | Mapping nanoparticles | 🖼🧊📄§ | 2026-04-14 | 2042-05-12 | 0 | 31 |
| 12599684 | Molecular probes and methods of use | 🖼🧊📄§ | 2026-04-14 | 2043-08-29 | 0 | 31 |
| 12599685 | Tumor stroma imaging agent and preparation method thereof | 🖼🧊📄§ | 2026-04-14 | 2040-10-13 | 0 | 31 |
| 12599629 | Coagulation mold, a kit and a method for preparing a coagulated blood mass | 🖼🧊📄§ | 2026-04-14 | 2045-01-21 | 0 | 31 |
| 12599607 | Pharmaceutical compositions comprising timolol | 🖼🧊📄§ | 2026-04-14 | 2044-07-19 | 0 | 31 |
| 12599610 | Solid dosage formulations of an orexin receptor antagonist | 🖼🧊📄§ | 2026-04-14 | 2044-04-09 | 0 | 31 |
| 12599613 | Composition comprising dutasteride | 🖼🧊📄§ | 2026-04-14 | 2039-12-13 | 0 | 31 |
| 12599612 | Pharmaceutical use | 🖼🧊📄§ | 2026-04-14 | 2041-06-15 | 0 | 31 |
| 12599618 | System and method for aerobic respiratory treatment | 🖼🧊📄§ | 2026-04-14 | 2043-10-09 | 0 | 31 |
| 12599621 | Enhancing anti-tumor response in melanoma cells with defective sting signaling | 🖼🧊📄§ | 2026-04-14 | 2041-01-21 | 0 | 31 |
| 12599619 | Method of treating blepharitis or conjunctivitis | 🖼🧊📄§ | 2026-04-14 | 2042-05-03 | 0 | 31 |
| 12599622 | Compounds to modulate intestinal absorption of nutrients | 🖼🧊📄§ | 2026-04-14 | 2042-11-09 | 0 | 31 |
| 12599627 | Method of treating cancer cells using copper hydroxide nitrate/calcium silicate/graphitic carbon nitride nanocomposite material | 🖼🧊📄§ | 2026-04-14 | 2045-05-30 | 0 | 31 |
| 12599624 | Biodegradable lung sealants | 🖼🧊📄§ | 2026-04-14 | 2042-08-30 | 0 | 31 |